← Back
$BHC All transactions

Bausch Health Companies Inc.

▲ BUY
8 / 10

Conviction

$ Value

$15.6M

Shares

2,500,000

Price

$6

Filed

Nov 28

Why this score? (8/10)
  • Open market buy (+3)
  • Trade value >= $5.0M (+3)
  • 10%+ owner (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

PAULSON & CO. INC.

Title

CIK

0001035674

Roles

10% Owner

Transaction Details

Transaction Date

2025-11-25

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

73,255,869

Footnotes

Paulson & Co. ("Paulson") is the investment manager of certain investment funds (the "Funds"). John Paulson is the controlling person of Paulson. All securities reported on this Form 4 are owned by the Funds. Each of Paulson and John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any securities not directly owned by such reporting person.

Filing Info

Accession No.

0001013594-25-001474

Form Type

4

Issuer CIK

0000885590

PAULSON & CO. INC.'s History

Date Ticker Type Value
2026-04-16 THM $12.6M
2026-03-03 THRY $1.7M
2026-03-02 THRY $2.5M
2026-02-27 THRY $2.0M
2026-01-29 THM $3.3M
2026-01-28 THM $21.8M
2026-01-27 THM $40.0M
2025-11-25 BHC $15.6M
2025-09-03 AAMI $57.6M
2025-06-16 PPTA $100.0M

Other Insiders at BHC (90d)

Insider Bought Sold Last
LEUNG SANDRA 2026-03-31
Paulson John 2026-03-31
WECHSLER AMY B 2026-03-31
APPIO THOMAS
Chief Executive Officer
2026-03-02
Charhon Jean-Jacques
EVP, CFO
2026-02-27
LEE STEVEN HYOSIG
SVP, Controller & CAO
2026-02-25
Carson Seana
EVP, General Counsel
$115K 2026-03-03
Lenar Aimee J.
EVP, US Pharma
2026-02-26